The role of interleukin-1β in direct and toll-like receptor 4-mediated neutrophil activation and survival

American Journal of Pathology

Volumn 165, Issue 5, 2004, Pages 1819-1826

  Prince, Lynne R ^a   Allen, Lucy ^a   Jones, Elizabeth C ^a   Hellewell, Paul G ^a   Dower, Steven K ^a   Whyte, Moira K B ^a   Sabroe, Ian ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; CD11B ANTIGEN; CELL SURFACE RECEPTOR; CYTOKINE; INTERLEUKIN 1; L SELECTIN; MEMBRANE PROTEIN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL ADHESION; CHEMISTRY; DOSE RESPONSE; INFLAMMATION; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIME; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD11B; APOPTOSIS; CELL ADHESION; CELL SURVIVAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; INTERLEUKIN-1; L-SELECTIN; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEUTROPHIL ACTIVATION; NEUTROPHILS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 7244219855     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63437-2     Document Type: Article

References (42)

1. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer 1972, 26:239-257
2. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C: Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989, 83:865-875
3. Ward I, Dransfleld I, Chilvers ER, Haslett I, Rossi AG: Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol Sci 1999, 20:503-509
4. Colotta F, Re F, Polentarutti N Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992, 80:2012-2020
5. Bossu P, del Grosso E, Cesaroni MP, Maurizi G, Balestro N, Stoppacciaro A, del Giudice E, Ruggiero P, Boraschi D: Balance between autocrine interleukin-1beta and caspases defines life versus death of polymorphonuclear cells. Eur Cytokine Netw 2001, 12:177-186
6. Grutkoski PS, D'Amico R, Ayala A, Simms HH: IL-1beta stimulation induces paracrine regulation of PMN function and apoptosis. Shock 1999, 12:373-381
7. Watson RW, Rotstein OD, Parodo J, Bitar R, Marshall JC, William R, Watson G: The IL-1 beta-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1 beta. J Immunol 1998, 161:957-962
8. Moulding DA, Quayle JA, Hart CA, Edwards SW: Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood 1998, 92:2495-2502
9. Arend WP: Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist. Semin Arthritis Rheum 2001, 30:1-6
10. Jordan JA, Guo RF, Yun EC, Sarma V, Warner RL, Crouch LD, Senaldi G, Ulich TR, Ward PA: Role of IL-18 in acute lung inflammation. J Immunol 2001, 167:7060-7068
11. Dunne A, O'Neill LA: The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003, 2003(171):re3
12. Leung BP, Culshaw S, Gracie JA, Hunter D, Canetti CA, Campbell C, Cunha F, Liew FY, McInnes IB: A role for IL-18 in neutrophil activation. J Immunol 2001, 167:2879-2886
13. Sabroe I, Prince LR, Jones EC, Horsburgh MJ, Foster SJ, Vogel SN, Dower SK, Whyte MK: Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 2003, 170:5268-5275
14. Sabroe I, Prince LR, Dower SK, Walmsley S, Chilvers ER, Whyte MKB: What can we learn from highly purified neutrophils? Biochem Soc Trans 2004, 32:468-469
15. Sabroe I, Jones EC, Usher LR, Whyte MK, Dower SK: Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 2002, 168:4701-4710
16. Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal 2001, 13:85-94
17. Xing L, Remick DG: Relative cytokine and cytoklne inhibitor production by mononuclear cells and neutrophils. Shock 2003, 20:10-16
18. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ: Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000, 165:618-622
19. Cotter MJ, Norman KE, Hellewell PG, Ridger VC: A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am J Pathol 2001, 159:473-481
20. Rowe SJ, Allen L, Ridger VC, Hellewell PG, Whyte MK: Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J Immunol 2002, 169:6401-6407
21. Whyte MK, Meagher LC, MacDermot J, Haslett C: Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 1993, 150:5124-5134
22. Usher LR, Lawson RA, Geary I, Taylor CJ, Bingle CD, Taylor GW, Whyte MK: Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 2002, 168:1861-1868
23. Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D: Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 1995, 85:532-540
24. Dransfield I, Buckle AM, Savill JS, McDowall A, Haslett C, Hogg N: Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J Immunol 1994, 153:1254-1263
25. Croston GE, Cao Z, Goeddel DV: NF-kappa B activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. J Biol Chem 1995, 270:16514-16517
26. Giri JG, Wells J, Dower SK, McCall CE, Guzman RN, Slack J, Bird TA, Shanebeck K, Grabstein KH, Sims JE: Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol 1994, 153:5802-5809
27. Strieter RM, Kunkel SL: Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Invest Med 1994, 42:640-651
28. Lee A, Whyte MK, Haslett C: Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993, 54:283-288
29. Mizgerd JP, Spieker MR, Doerschuk CM: Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type IIL-1 receptor during Escherichia coll pneumonia in mice. J Immunol 2001, 166:4042-4048
30. Parsey MV, Kaneko D, Shenkar R, Abraham E: Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of IL-1 beta. Clin Immunol 1999, 91:219-225
31. Lord PC, Wilmoth LM, Mizel SB, McCall CE: Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest 1991, 87:1312-1321
32. Malyak M, Smith Jr MF, Abel AA, Arend WP: Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. J Clin Immunol 1994, 14:20-30
33. Bourke E, Cassetti A, Villa A, Fadlon E, Colotta F, Mantovani A: IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils. J Immunol 2003, 170:5999-6005
34. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A: Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993, 261:472-475
35. Re F, Muzio M, De Rossi M, Polentarutti N, Giri JG, Mantovani A, Colotta F: The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 1994, 179:739-743
36. Malyak M, Smith Jr MF, Abel AA, Hance KR, Arend WP: The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes. J Immunol 1998, 161:2004-2010
37. Re F, Mengozzi M, Muzio M, Dinarello CA, Mantovani A, Colotta F: Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells. Eur J Immunol 1993, 23:570-573
38. Hojo Y, Ikeda U, Ohya K, Ichida M, Kario K, Takahashi M, Ikeda M, Minota S, Isumi Y, Minamino N, Ishimitsu T, Shimada K: Interaction between monocytes and vascular endothellal cells induces adrenomedullin production. Atherosclerosis 2001, 155:381-387
39. Liu L, Roberts AA, Ganz T: By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 2003, 170:575-580
40. Furie MB, McHugh DD: Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-alpha. J Immunol 1989, 143:3309-3317
41. Zwijnenburg PJ, van der Poll T, Florquin S, Roord JJ, Van Furth AM: IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis. J Immunol 2003, 170:4724-4730
42. Olsen NJ, Stein CM: New drugs for rheumatoid arthritis. N Engl J Med 2004, 350:2167-2179